DELCATH SYSTEMS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
DELCATH SYSTEMS, INC. (DCTH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $11.27 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $10.82, a 10.41% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $9.80, a 61.18% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $6.08, a 46.76% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $11.42, a 9.60% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $10.63, a 89.15% increase from fiscal 2024.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $5.62, a 19.94% decline from fiscal 2023.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $7.02, a 26.80% decline from fiscal 2022.
- DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $9.59, a 9.44% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $11.27 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | $10.82 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | $10.63 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $10.33 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | $9.88 10-Q · filed 2025-08-06 | ||||
| 2025-03-31 | $9.80 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | $5.62 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | $5.73 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | $5.88 10-Q · filed 2024-08-05 | ||||
| 2024-03-31 | $6.08 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $7.02 10-K · filed 2024-03-26 | ||||
| 2023-09-30 | $7.22 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $10.36 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | $11.42 10-Q · filed 2023-05-22 | ||||
| 2022-12-31 | $9.59 10-K · filed 2023-03-27 | ||||
| 2022-09-30 | $9.69 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | $10.35 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | $10.42 10-Q · filed 2022-05-11 | ||||
| 2021-12-31 | $10.59 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | $11.67 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | $11.67 10-Q · filed 2021-08-10 | ||||
| 2020-12-31 | $196.70 10-K · filed 2021-03-31 | ||||
| 2019-12-31 | $196.70 10-K · filed 2020-03-25 | ||||
| 2019-09-30 | $0.28 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | $0.28 10-Q · filed 2019-08-08 | ||||
| 2019-03-31 | $0.28 10-Q · filed 2019-07-17 | ||||
| 2017-12-31 | $6664.00 10-K · filed 2018-03-16 | ||||
| 2016-12-31 | $8382.50 10-K · filed 2018-03-16 | $23.95 10-K · filed 2017-03-29 | |||
| 2015-12-31 | $168056.00 10-K · filed 2018-03-16 | $30.01 10-K · filed 2016-03-18 | |||
| 2014-12-31 | $67.58 10-K · filed 2016-03-18 | ||||
| 2013-12-31 | $24.47 10-K · filed 2016-03-18 | ||||
| 2013-09-30 | $3.63 10-Q · filed 2013-11-06 | ||||
| 2013-06-30 | $3.45 10-Q · filed 2013-08-06 | ||||
| 2013-03-31 | $3.62 10-Q · filed 2013-05-09 | ||||
| 2012-12-31 | $5.05 10-K · filed 2013-03-13 | ||||
| 2012-09-30 | $4.98 10-Q · filed 2012-11-07 | ||||
| 2012-06-30 | $4.75 10-Q · filed 2012-08-08 | ||||
| 2011-12-31 | $4.65 10-K · filed 2013-03-13 | ||||
| 2010-12-31 | $4.81 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |